Insights to aging prediction with AI based epigenetic clocks.

Journal: Epigenomics
PMID:

Abstract

Over the past century, human lifespan has increased remarkably, yet the inevitability of aging persists. The disparity between biological age, which reflects pathological deterioration and disease, and chronological age, indicative of normal aging, has driven prior research focused on identifying mechanisms that could inform interventions to reverse excessive age-related deterioration and reduce morbidity and mortality. DNA methylation has emerged as an important predictor of age, leading to the development of epigenetic clocks that quantify the extent of pathological deterioration beyond what is typically expected for a given age. Machine learning technologies offer promising avenues to enhance our understanding of the biological mechanisms governing aging by further elucidating the gap between biological and chronological ages. This perspective article examines current algorithmic approaches to epigenetic clocks, explores the use of machine learning for age estimation from DNA methylation, and discusses how refining the interpretation of ML methods and tailoring their inferences for specific patient populations and cell types can amplify the utility of these technologies in age prediction. By harnessing insights from machine learning, we are well-positioned to effectively adapt, customize and personalize interventions aimed at aging.

Authors

  • Joshua J Levy
    DOE Joint Genome Institute, 2800 Mitchell Dr, Walnut Creek, CA, 94598, USA.
  • Alos B Diallo
  • Marietta K Saldias Montivero
    Program in Quantitative Biomedical Sciences, Dartmouth College Geisel School of Medicine, Hanover, NH, USA.
  • Sameer Gabbita
    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
  • Lucas A Salas
    Department of Epidemiology, Lebanon, USA.
  • Brock C Christensen
    Department of Epidemiology, Lebanon, USA. Brock.C.Christensen@dartmouth.edu.